Decycle Bio uses its SynthomeAI platform and cell-free enzyme engineering to convert industrial waste streams into sustainable, high-performance chemicals that are cost-competitive with petrochemical-derived alternatives.
Decycle Bio utilizes its proprietary SynthomeAI platform to engineer compact, multi-enzyme pathways for cell-free chemical manufacturing. By leveraging de novo pathway design and advanced enzyme engineering, the company transforms industrial outputs—such as CO2, biomass, and waste streams—into sustainable, high-performance chemicals. Unlike traditional microbial fermentation, Decycle Bio's cell-free approach allows for greater control, increased energy efficiency, and faster, more selective chemical production. The resulting biomanufactured products are engineered to be indistinguishable from their conventional counterparts while meeting industry-leading specifications.
This technology provides a sustainable alternative for companies looking to reduce reliance on petrochemical-derived products. By optimizing for pathway length, thermodynamics, and cofactor utilization, Decycle Bio achieves competitive commercial economics without compromising on cost, quality, or performance. The company focuses on identifying and replacing chemicals that are predominantly derived from petrochemicals, assisting partners in meeting sustainability goals through scalable and efficient biomanufacturing processes.